ArticleCureus2026
Impact of the COVID-19 Pandemic on Outpatient Visit-Based Frequency Trends of Herpes Zoster Ophthalmicus.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Herpes zoster ophthalmicus (HZO) is a vision-threatening disease, yet the long-term impact of the COVID-19 pandemic on its relative frequency and ocular complication profile remains insufficiently understood. This retrospective observational study aimed to quantitatively evaluate the pandemic's influence on the long-term relative frequency trends of HZO and its ocular complications. We analyzed 15 years of clinical data from January 2011 to June 2025 at a single institution in Japan. Interrupted time series analysis was employed to distinguish immediate level changes from long-term trend changes in disease relative frequency following the pandemic's onset in early 2020. Comparing the pre-pandemic and post-pandemic cohorts, the mean age of patients with HZO increased significantly by approximately eight years, and the proportion of cases complicated by uveitis increased from 22.7% to 41.6%. While the time series analysis indicated no immediate surge in the relative frequency of HZO at the pandemic's start, it revealed a highly significant acceleration in the long-term increasing trend of HZO cases. Furthermore, the frequency trend of herpetic uveitis exhibited a similar and statistically significant upward shift during the post-pandemic period. These findings suggest that the pandemic period was associated with a transient fluctuation in healthcare utilization, but it was also associated with a sustained acceleration in the relative frequency of HZO and a notably higher frequency of HZO-associated uveitis. The pronounced increase in cases among older adults underscores the critical importance of proactive herpes zoster vaccination and enhanced ophthalmic triage to prevent permanent vision loss in the post-pandemic era.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.